Human cytomegalovirus (HCMV) purified from urine or tissue culture supernatant has been reported to contain fl2-microglobulin (fl 2m), which forms the light chain of HLA class I molecules. It has been postulated that HCMV covered with fl2m binds to HLA class I s-chains at the cell surface. In the present study we used transfected human and mouse cell lines expressing distinct allelic forms of HLA class I and fl2m to determine whether HLA class I molecules could act as cellular receptors for HCMV. The susceptibility of cells to HCMV infection was estimated by calculating the percentage of cells expressing HCMV immediate early antigens. Although the results showed some variation between different transfected cell clones, no correlation was found between expression of HLA class I on the cell membrane and HCMV infection. Preincubation of HLA class I-positive cells with antibodies against HLA class I antigens inhibited HCMV infection after binding and adsorption of HCMV. Trypsin prevented HCMV infection of both class I-positive and class I-negative cells. We conclude that these results do not support the assumption that HLA class I molecules are functional receptors for HCMV.
Introduction
Infection of a host cell by a virus usually starts with specific and firm binding to one or more host cell surface structures called receptors, which may take the form of carbohydrate, lipid or protein. It has been postulated that they bind to highly conserved epitopes on the inner wall of small pockets on the viral envelope or capsid that are inaccessible to antibodies (Rossmann et al., 1985) . Recently, some viruses have been shown to use members of the immunoglobulin (Ig) superfamily as cell surface receptors (White & Littman, 1989) . Molecules bearing resemblance to antibody constant region domains are numerous at the cell surface because they have recognition and binding functions (Williams & Barclay, 1988) . They may be suitable virus receptors because of the relatively small size of the Ig-like domains (White & Littman, 1989) .
Human cytomegalovirus (HCMV), a member of the herpesvirus family, is one of the most common viral pathogens of man, causing significant morbidity and mortality in newborn children and immunocompromised individuals (Ho, 1982) . The specific cellular receptor site for HCMV has not been identified, but evidence indicating that HCMV binds to a host cell 0001-0299 © 1991 SGM membrane molecule has been provided by Grundy et al. (1987a) and McKeating et al. (1987) , who have shown that HCMV purified from urine or culture supernatant contains fl2-microglobulin (fl2m). fl2m is a small polypeptide with structural similarity to the Ig superfamily proteins and forms the light chain of major histocompatibility complex (MHC) class I molecules. On the cell surface, fl2m complexed to the s-chain of HLA class I can exchange with free fl2m present in body fluids or culture medium (Bernabeu et al., 1984) . Grundy et al. (1987b) have shown that fl2m in tissue culture medium increases the infectivity of HCMV and postulate that HCMV particles coated with fl2m bind to the cell surface by replacing fl2m from HLA class I molecules. In support of this hypothesis, they have shown that Raji cells are more sensitive to HCMV than Daudi cells, which do not express HLA class I antigens owing to impaired synthesis of fl2m (de Preval &Mach, 1983) . Raji and Daudi cells are not only different with respect to their HLA class I expression, but are lymphoblastoid cell lines that are largely resistant to HCMV (Tocci & St George, 1979) , so no definite conclusions can be drawn from these studies. Furthermore, because class I allelic forms display large differences with respect to their rate of assembly and exchange of fl2m (Hyafil & Strominger, 1979; Neefjes & Ploegh, 1988) , it seemed of interest to determine whether class I allelic forms display similar differences with regard to the proposed interaction with /~2m-coated HCMV particles.
In the present study we investigated various aUelic forms of HLA class I molecules as possible cellular receptors for HCMV. For this purpose, we infected mouse L cells and human small cellular lung carcinoma cells (GCL2) which stably expressed HLA class I molecules and human/~2m (h/~2m) after gene transfer. GLC2 cells are tumour cells of neuroendocrine origin and normally do not express detectable levels of either HLA class I or fl2m due to some unknown defect at the transcriptional level (Stam et al., 1990) . Both L and GLC2 cell lines supported an abortive HCMV infection, resulting in the expression of HCMV immediate early antigens (lEAs). By identifying infected cells with the use of anti-HCMV lEA monoclonal antibodies (MAbs), we compared the sensitivity to HCMV of various HLA class I-and hfl2m-expressing cell clones.
Methods
Cell cultures. Mouse L cells and GLC2 cells (de Leij et al., 1985) were cultured in Dulbecco's modification of Eagle's medium containing 10 % foetal calf serum (FCS), 100 international units/ml penicillin, 0.1 ~tg/ml streptomycin and 2 Ixg/ml amphotericin. Transfected cells were kept in HAT medium or in medium supplemented with 450 ~tg/ml G418 (Gibco).
Transfected cell lines. Transfected L and GLC2 cells were obtained from the Netherlands Cancer Institute (Anthony van Leeuwenhoekhuis), Amsterdam. Transfected cell lines were analysed for the expression of HLA class I or h/~2m by flow cytometry. Cell populations expressing heterogeneous levels of the cloned genes were subcloned prior to use. L cells transfected with HLA-B14, HLA-B38 and HLA-B51 were a generous gift from Professor C. Mfiller, EberhardKarls-Universit~it, Tfibingen, Germany.
Transfection. The stable transfection of L and GLC2 cells has been described (Stam et al., 1990) . Briefly, L cells lacking thymidine kinase (tk) activity (Ltk-) and GLC2 cells were used as recipient cells for transfection. Cells were transfected by DNA-mediated gene transfer using the calcium phosphate precipitation method. L cells were cotransfected with the herpes simplex virus (HSV) tk gene as a selectable marker; GLC2 cells were cotransfected with the neomycin resistance (neo r) gene as a selectable marker. L cells were either singly transfected with genes encoding HLA class I s-chains or doubly transfected with genes encoding HLA class I c~-chains and genes encoding h/~2m. Double transfectants were obtained by carrying out a first round of transfection into Ltk-cells and cotransfection with the HSV tk gene. Ltk ÷ cells were used as recipients in a second round of transfection, using the neo r gene as a selectable marker. Double transfectants were selected in medium containing HAT and 450 ~tg/ml G418.
Antibodies. MAb W6/32 (Barnstable et al., 1978) recognizes a shared determinant on HLA-A, -B and -C when complexed to human or bovine fl2m, and shows no cross-reactivity with mouse L cells; MAb BBM 1 (Brodsky et al., 1979) recognizes both free and complexed h/~ 2m.
MAbs 36-7-5S (Sachs et al., 1981) , BB7.2 (Parham & Brodsky, 1981) , ME1 (Ellis et al., 1982) and KS3 (Sakaguchi et al., 1988) were kindly provided by Dr F. Kievits, Central Laboratory of the Netherlands Red Cross Blood Transfusion Service (CLB), Amsterdam. MAb 36-7-5S is specific for H-2Kk; MAb BB7.2 is specific for HLA-A2; MAb ME1 recognizes an epitope present on HLA-B27, -B7 and -BW22; MAb KS3 recognizes an epitope present on HLA-B27, -B7, -BW42, -BW22, -BW67 and -BW73. Polyclonal rabbit anti-heavy chain serum, which reacts specifically with free HLA class I ~-chains, has been described elsewhere (Neefjes & Ploegh, 1988) . For the detection of the 72K immediate early nuclear protein of HCMV, we used MAb 2H2.4 (Du Pont) (Gleaves et al., 1984) Virus. Laboratory strain AD 169 of HCMV was propagated in human foetal lung fibroblasts(passages 7 to 20) in the presence of 8% FCS. Virus was harvested as soon as more than 90% of the cells showed c.p.e.
HCMV infection assay.
Subconfluent monolayers of cells on glass coverslips were incubated with 100 ~tl of twofold dilutions of HCMV AD169 for 1 h at 37 °C to allow adsorption. Following adsorption, cells were cultured at 37 °C for 24 h in medium containing 4% FCS and then fixed for 10 min in cold methanol (-20 °C) containing 0.1% acetic acid. Fixed cell layers were blocked for 30 min at room temperature with 2% BSA in PBS and incubated for 30 min with 100 p.l purified anti-HCMV IEA MAb 2H2.4, diluted 1:100 in PBS containing 1% BSA. After three washes in PBS, cells were incubated for 45 rain at room temperature with FITC-conjugated rabbit anti-mouse IgG. After three washes in PBS, substrates were mounted in 10% (w/v) glycerol in PBS and examined for nuclear immunofluorescence. The percentage of cells with fluorescent nuclei was calculated from counts of at least 200 cells.
Double immunofluorescence staining was performed by incubating fixed monolayers of L cells with a mixture of purified anti-HCMV IEA MAb (diluted 1:100) and rabbit anti-heavy chain serum (diluted 1:200). As the second antibody we used a mixture of TRITCconjugated goat anti-mouse IgG (diluted 1:100) and FITC-conjugated horse anti-rabbit IgG (diluted 1 : 100). Double-stained monolayers were examined for membrane and nuclear immunofluorescence in a Leitz fluorescence microscope equipped with appropriate excitation filters for the detection of fluorescein and rhodamine.
Blocking studies with MAbs. Monolayers of L cells, cultured in fiatbottom 96-well titre plates (Nunclon), were incubated for 45 min at 4 °C with 50 ~tl MAbs (ascites fluid, diluted 1:25 in serum-free medium). After incubation, medium containing the unbound MAb was removed and cells were incubated with HCMV (at an m.o.i, of 2) for 1 h at 4 °C. Infection was performed at 4 °C to avoid expression of class I molecules during adsorption. After adsorption, the virus inoculum was removed and cells were washed three times in PBS containing 1% BSA to remove unbound virus. Infected monolayers were cultured at 37 °C for 24 h in medium containing 4% FCS (inactivated for i h at 56 °C). Cells were fixed without drying for 10 min at -20 °C in methanol and (a)
Log,,, fluorescence intensity analysed for HCMV IEA expression by immunofluorescence as described above.
Results

Expression of MHC class I and fl2m on the membranes of transfected cell lines
Mouse L and human GLC2 cells were either singly transfected with distinct HLA class 1 heavy chains (a-chains) or doubly transfected with HLA class I a-chains and human fl2m (hfl2m), as summarized in Table 1 . Transfected clones were analysed for expression of MHC class I antigens on the membrane by flow cytometry, using anti-HLA class I MAb W6/32, antihfl2m MAb BBM1 or anti-H-2K k MAb 36-7-5S. L cells cotransfected with hfl2m, i.e. HLA-A2/hfl2m and HLA-B27/hfl 2m cells, expressed higher levels of surface HLA class I than L cells transfected only with the 0t-chain of HLA-A2, HLA-B7, HLA-B14, HLA-B27, HLA-B38, HLA-B51, HLA-Cw2 or HLA-Cw3. All L cell lines tested expressed the same level of H-2K k antigen.
Control GLC2 cells showed no detectable levels of surface HLA class I or hfl2m, whereas GLC2 cells transfected with HLA-A2 and hfl2m, or HLA-B27 and hfl2m expressed readily detectable levels of either HLA class I or hfl2m antigens on the cell surface.
The level of expression of class I and hfl2m antigens on the transfected L and GLC2 cells are shown for HLA-A2-and HLA-B27-transfected cells in Fig. 1 . cells. However, an exception was that up to a twofold greater number of HLA-B27/hf12m-expressing cells than control cells were IEA-positive at all virus dilutions (Fig. 2) .
Double staining of HLA class I and HCMV lEA
To exclude the possibility that the elevated levels of HCMV tEA in HLA-B27/hf12m-expressing L cells was determined by differences between cell layers or their culture conditions, we performed infection studies on mixed cultures of HLA class 1-positive and control L ceils. Monolayers of heterogeneous cell populations were incubated with serial dilutions of HCMV and subjected to a two colour immunofluorescence technique. HCMV IEA stained red using mouse anti-HCMV IEA MAb and TRITC-conjugated goat anti-mouse serum; HLA class I antigens stained green with a polyclonal rabbit anti-HLA class I ~-chain serum and FITC-conjugated horse anti-rabbit serum. The numbers of IEA-positive and -negative cells were then determined for both the class 1-positive and class I-negative cells present in one monolayer. The results showed clearly that HCMV IEA expression was increased in HLA-B27/hf12m-expressing cells, whereas HLA-A2/hfl2m and HLA-Cw3-positive cells showed no such increase (Fig. 3) .
Blocking of HCMV infection with anti-HLA class I MAbs
To determine whether antibodies directed to HLA class I antigens could prevent a subsequent HCMV infection, L shown in Table 2 . Preincubation with anti-H-2K k MAb 36-7-5S, monomorphic anti-HLA class I MAb W6/32 or anti-hfl2m MAb BBM1 reduced HCMV lEA expression in transfected and control cells to the same degree, indicating that the effect of preincubation was not related to specific binding of the MAbs to the cells. In contrast, anti-HLA-A2 MAb BB7.2, anti-HLA-B27 MAb ME1 and anti-HLA-B27 MAb KS3 inhibited HCMV IEA expression significantly in cells expressing the appropriate HLA class I antigens (P<0.001, P < 0.01, P < 0.05 respectively). However, addition of these MAbs 1 h after infection also reduced HCMV infection (P < 0.001 for all three MAbs).
Expression of HCMV IEA in class I-transfected GLC2 cells
To exclude the possible influence of H-2 class I antigens or mouse fl2m on the results seen with the L cells, we used GLC2 cells as a target for HCMV. GLC2 cells normally do not express HLA class I and fl2m. Transformed GCL2 cells, expressing HLA-A2/hfl2m or HLA-B27/ hfl2m, and control GLC2 cells were tested for their susceptibility to HCMV infection in the same manner as described for the L cells. The results showed that untransfected GLC2 cells, although negative for HLA class I, readily expressed HCMV IEA after infection. The average percentage of infected cells was higher than that observed for the control L cells. However, HCMV IEA expression did not increase in transfected GLC2 cells expressing HLA-A2/hfl2m or HLA-B27/hf12m compared to that in control GLC2 cells. Unlike the HLA-B27/hf12m-expressing L cells, GLC2 cells expressing HLA-B27/hf12m showed lower levels of IEA than HLA-A2/hfl2m-transfected or control GLC2 cells (Fig. 4) . 
Susceptibility of trypsinized cells to HCMV
The ready expression of HCMV IEA upon incubation of class I-negative GLC2 cells with HCMV suggested the presence of HCMV receptor structures other than HLA class I. We considered the possibility that these putative receptor structures could mask a minor contribution of HLA class I to the adsorption of HCMV. This led us to make an effort to analyse HCMV infection in L and GLC2 cells that had been treated for 10 min at 37 °C with 50 ~tg/ml trypsin (Difco). Trypsin is a protease which has been reported to reduce binding of HCMV to the cell surface (Taylor & Cooper, 1989) and does not affect HLA class I molecules (Atwood & Norkin, 1989) .
Treatment of cells with trypsin prior to infection decreased HCMV IEA expression by more than 90~ in both L and GLC2 cells. However, the susceptibility to HCMV after trypsinization was not increased in any of the class I-transfected cell clones relative to the class Inegative control cells. The results for GLC2 cell clones are shown in Fig. 5 .
Discussion
In this study, the possibility that HLA class I molecules act as cell surface receptors for HCMV was evaluated using transformed cell lines. The ability to increase virus binding activity and infection by gene transfer has already been used as an important criterion for confirmation of the identify of other well characterized virus receptors (White & Littman, 1989) . To estimate the receptor-mediated entry of HCMV, we counted the cells that expressed HCMV IEA in the infected monolayers. HCMV IEA are non-structural regulatory proteins and are the first viral proteins to be expressed after infection (Stinski et al., 1983) . The use of HCMV lEA expression as a marker of infection excluded any influence of nonspecific virus binding, i.e. binding that is not mediated by a specific receptor and probably does not lead to infection. A potential limitation of lEA expression as the marker of infection is the requirement of a cell to be able to express the IEA genes, which may also be dependent on factors such as cell cycle, cell differentiation and the nutritional state of the cell (Boom et al., 1988) .
Our results did not indicate any relationship between HLA class I expression and HCMV infection. Nine L cell lines expressing various HLA-A, -B and -C locus products showed no increase of HCMV IEA expression relative to that of control cells. As an exception to this, the number of HLA-B27/hf12m doubly transfected L cells expressing HCMV IEA was up to twofold that of controls. Comparison of HLA-A2/hfl2m-and HLA-A2-transfected L cells provided no evidence that the expression of hfl2m as such led to increased HCMV IEA expression. Furthermore, by using mixed cell cultures we excluded the possibility that variations in culture conditions could have been responsible for the observed difference. Therefore, we considered the possibility that expression of HLA-B27/hf12m on L cells could increase their susceptibility to HCMV infection. However, other cells expressing HLA-B27, in this case GLC2 cells transfected with HLA-B27 and hfl2m, or L cells transfected with HLA-B27 without hfl2m, did not show increased IEA expression. Furthermore, the HLA-B27/ hfl2m-expressing L cells did not show increased sensitivity to HCMV after they had been treated with trypsin, which is a protease that inhibits receptor-mediated binding of HCMV, but does not affect class I molecules (Taylor & Cooper, 1989) . Therefore, the data did not consistently indicate a differential role of HLA-B27, although we have not excluded this possibility by analysing separately transfected HLA-B27/hf12m L cell clones.
Interestingly, preincubation of transfected L cells with MAbs to HLA-A2 or HLA-B27 resulted in significant inhibition of HCMV IEA expression in cells expressing the appropriate class I antigens. However, this inhibition could also be obtained when the MAbs were added after virus binding and adsorption, which strongly suggests that the inhibition of HCMV infectivity by anti-class I MAbs can not be explained by a direct interaction between anti-class I MAbs and viral antigen-receptor binding. An alternative explanation might be that the inhibition of HCMV by anti-HLA class I MAbs results from the ability of anti-class I MAbs to interfere with cell activation pathways (Akiyama et al., 1985) . Early activation of host cells, probably induced by binding of HCMV to its receptor, has been shown to be of crucial importance in the HCMV replication cycle (Albrecht et aL, 1989 ). An early post-infection signal interfering with cell activation has also been proposed to explain inhibition of human immunodeficiency virus type 1 (HIV-1) replication by anti-fl2m MAb (Corbeau et al., 1990) . In this latter case, HIV-1 replication was inhibited when anti-fl2m antibodies were added between 1 and 2 h after infection. Interestingly, anti-class I MAbs have also been reported to protect against murine CMV (MCMV) infection, although only anti-Dd,K d ascites and no other anti-H-2 class I antibodies inhibited infection (Price et al., 1987) . In the mouse model H-2 class I loci have been found to determine sensitivity to MCMV (Price et al., 1990) so it would be of interest to determine the conditions and the mechanism of action by which anticlass I MAbs interfere with early HCMV infection to find out whether HLA class I could still play some role in HCMV entry.
To exclude the possibility that mouse H-2 class I molecules or mouse fl2m influenced the results obtained with the L cells, we performed similar infection studies with human GLC2 cells. However, transfected GLC2 cell clones did not show higher HCMV IEA expression than control cells. Although completely devoid of cell surface HLA class I, control GLC2 cells could be readily infected with HCMV, which is in agreement with reports of experiments showing that Daudi cells bind HCMV and support restricted HCMV infection (Taylor & Cooper, 1989; Grundy et al., 1987b) . Our findings with the class I-negative GLC2 cells, as well as the findings with class I-negative Daudi cells, further substantiated the hypothesis that HLA class I transplantation antigens are not required for adsorption and penetration of HCMV.
The present findings, although based on observations using the same culture conditions and virus strain, but different cell types, do not support the initial findings of Grundy et al. (1987b) . Based on the assumptions that HCMV binds fl2m on the outside of the viral envelope and that HCMV and the class I heavy chain bind fl2m at different sites, they postulated that fl2m acts as a bridge between HCMV and the cell surface and that HLA class I molecules serve as functional receptors. More recently, studies on the interaction between HCMV and fl2m, and efforts to characterize the HCMV receptor have argued against this hypothesis. First, electron microscopy studies performed with gold-labelled hfl2m did not provide evidence that fl2m binds to the outside of the viral envelope, but indicated that fl2m binds to the tegument of HCMV particles with a ruptured envelope (Stannard, 1989) . Second, Beck and coworkers have provided evidence that HCMV encodes a class I heavy chain homologue which interacts with fl2m (Beck & Barrell, 1988; Browne et al., 1990) . Binding of fl2m by a viral class I homologue would preclude simultaneous binding to host HLA class I g-chains. Third, studies with proteases have shown that binding of HCMV is inhibited by trypsin, which is a protease that does not affect HLA class I molecules (Atwood & Norkin, 1989; Taylor & Cooper, 1989) . Fourth, experiments making use of separated fibroblast membrane constituents and studies done with an anti-idiotypic antibody to the 86K gH analogue (GcIII) of HCMV indicated that HCMV binds to membrane structures of 30K and 92.5K, respectively (Taylor & Cooper, 1990; Keay et al., 1989) . These MrS differ distinctly from the known Mr of class I subunits or their breakdown products. Finally, no specific binding of HCMV to fl2m or HLA class I or-chains purified by SDS-PAGE under minimally denaturing conditions has been observed (Taylor & Cooper, 1990) .
Taken together, these findings and the data presented here do not implicate HLA class I molecules as functional receptors for HCMV. However, determination of the structure of the HCMV receptor and elucidation of the role of fl2m in the HCMV infection cycle may provide new insight into the interaction of HCMV with its host.
